References
- Mitchison DA. The action of antituberculosis drugs in short-course chemotherapy. Tubercle 1985; 66: 219–25.
- Parthasarathy R, Raghupati Sarma G, Janardhanam B, et al. Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide. Tubercle 1986; 67: 99–108.
- Weber WW, Hein DW. Clinical pharmacokinetics of isoniazid. Clin Pharmacokin 1979; 4: 401–22.
- Bouveret JP, Hanoteau J, Gerbeaux J, Houin G, Tillement JP. Variations de l'indice d'inactivation de l'isoniazide au cours des traitements antituberculeux chez l'enfant. Arch Fr Pediatr 1983; 40: 615–19.
- Mount FW, Anastasiades AA, Schnack GA. Control study of biologically active isoniazid in serum of children with primary tuberculosis. Am Rev Respir Dis 1961;83: 173–83.
- Medical Research Council. Streptomycin treatment of tuberculous meningitis. Lancet 1948; 1: 582–96.
- Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979; 32: 607–29.
- Voorhoewe HWA. A new reference for the mid-upper arm circumference? J Trop Pediatr 1990; 36: 256–62.
- Gent WL, Seifart HI, Parkin DP, Donald PR, Lamprecht JH. Factors in hydrazine formation from isoniazid by paediatric and adult tuberculosis patients. Eur J Clin Pharmacol 1992; 43: 131–6.
- Gibaldi M, Perrier D. Pharmacokinetics, 2nd edn. New York: Marcel Dekker, 1982; 4–5.
- Lacroix C, Laine G, Goulle JP. Microdosage de l'isoniazide et de l'acetylisoniazide plasmatiques par Chromatographie liquide à haute performance. J Chromatogr 1984; 307: 137–44.
- Buchanan N, Eyberg C, Davis MD. Isoniazid pharmacokinetics in kwashiorkor. S Afr Med J 1979; 56: 299–300.
- Eriksson M, Bolme P, Habte D, Paalzow L. INH and streptomycin in Ethiopian children with tuberculosis and different nutritional status. Acta Paediatr Scand 1988; 77: 890–4.
- Weber WW, Hein DW. N-acetylation pharmacogenetics. Pharm Rev 1985; 37: 25–79.
- Chapron DJ, Blum MR, Kramer PA. Evidence for a trimodal pattern of acetylation of isoniazid in uremic subjects. J Pharm Sci 1978; 67: 1018–19.
- Mashimo M, Suzuki T, Abe M, Deguchi T. Molecular genotyping of N-acetylation polymorphism to predict phenotype. Hum Genet 1992; 90: 139–43.
- Hickman D, Sim E. N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. Biochem Pharmacol 1991; 42:1007–14.